Sartorius AG (ADR)
General ticker "SOAGY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $74.2B (TTM average)
Sartorius AG (ADR) follows the US Stock Market performance with the rate: 50.3%.
Estimated limits based on current volatility of 1.7%: low 47.59$, high 49.28$
Factors to consider:
- Company pays dividends (annually): last record date 2025-03-31, amount 0.16$ (Y0.33%)
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [28.21$, 55.90$]
- 2025-12-31 to 2026-12-31 estimated range: [28.12$, 55.09$]
Financial Metrics affecting the SOAGY estimates:
- Negative: with PPE of 51.1 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 12.93
- Positive: 19.40 < Shareholder equity ratio, % of 27.37 <= 42.68
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 0.78
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.82
- Positive: Inventory ratio change, % of -4.47 <= -0.75
- Negative: Industry inventory ratio change (median), % of 0.91 > 0.31
- Negative: 0.73 < Interest expense per share per price, % of 1.24
Short-term SOAGY quotes
Long-term SOAGY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €3,395.70MM | €3,380.70MM | €3,398.46MM |
| Operating Expenses | €2,851.80MM | €2,943.50MM | €2,772.77MM |
| Operating Income | €543.90MM | €437.20MM | €625.69MM |
| Non-Operating Income | €-157.90MM | €-250.40MM | €-301.99MM |
| Interest Expense | €144.90MM | €184.10MM | €190.19MM |
| R&D Expense | €170.80MM | €196.80MM | €167.13MM |
| Income(Loss) | €386.00MM | €186.80MM | €323.70MM |
| Taxes | €95.90MM | €49.40MM | €102.39MM |
| Profit(Loss)* | €205.20MM | €84.00MM | €148.79MM |
| Stockholders Equity | €2,067.30MM | €2,764.80MM | €2,705.65MM |
| Inventory | €1,036.70MM | €788.50MM | €791.86MM |
| Assets | €9,755.30MM | €10,103.00MM | €9,713.06MM |
| Operating Cash Flow | €853.60MM | €976.20MM | €630.11MM |
| Capital expenditure | €559.70MM | €409.90MM | €424.46MM |
| Investing Cash Flow | €-2,823.30MM | €-425.80MM | €-493.23MM |
| Financing Cash Flow | €2,165.70MM | €-128.30MM | €-394.39MM |
| Earnings Per Share** | €0.60 | €0.24 | €0.43 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.